Creating a complex IND whilst safeguarding confidential data between a CGT spin-off and CDMO
VCLS Blog » Cell Gene Therapy
by Yang Ding
3M ago
L’article Creating a complex IND whilst safeguarding confidential data between a CGT spin-off and CDMO est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Navigating the FDA Draft Guidance Document “Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products”
VCLS Blog » Cell Gene Therapy
by Yang Ding
6M ago
L’article Navigating the FDA Draft Guidance Document “Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products” est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Key CMC and NC considerations for cell and gene therapy development
VCLS Blog » Cell Gene Therapy
by Yang Ding
10M ago
L’article Key CMC and NC considerations for cell and gene therapy development est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Advanced Therapy and Medicinal Products: How to overcome the hurdles from bench to clinic ?
VCLS Blog » Cell Gene Therapy
by Marguerite Priol
1y ago
L’article Advanced Therapy and Medicinal Products: How to overcome the hurdles from bench to clinic ? est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
9 Challenges During Cell and Gene Therapy Development in Europe, and How to Tackle Them
VCLS Blog » Cell Gene Therapy
by Marguerite Priol
1y ago
L’article 9 Challenges During Cell and Gene Therapy Development in Europe, and How to Tackle Them est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Critical Materials considerations for Cell and Gene therapy product development – Part 2
VCLS Blog » Cell Gene Therapy
by Yang Ding
1y ago
L’article Critical Materials considerations for Cell and Gene therapy product development – Part 2 est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Critical Materials considerations for Cell and Gene therapy product development – Part 1
VCLS Blog » Cell Gene Therapy
by Yang Ding
1y ago
L’article Critical Materials considerations for Cell and Gene therapy product development – Part 1 est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Patient access to Advanced Therapies in Europe 2009-2021: from early access failures to current challenges
VCLS Blog » Cell Gene Therapy
by Zakaria Hijji
1y ago
L’article Patient access to Advanced Therapies in Europe 2009-2021: from early access failures to current challenges est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
Advice on Non-clinical and Clinical Development for ATMPs from an Ex-CAT member
VCLS Blog » Cell Gene Therapy
by Zakaria Hijji
1y ago
L’article Advice on Non-clinical and Clinical Development for ATMPs from an Ex-CAT member est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website
How to Successfully Manage The Challenges of Developing an ATMP
VCLS Blog » Cell Gene Therapy
by Elaine Goldfarb
1y ago
L’article How to Successfully Manage The Challenges of Developing an ATMP est apparu en premier sur Voisin Consulting Life Sciences ..read more
Visit website

Follow VCLS Blog » Cell Gene Therapy on FeedSpot

Continue with Google
Continue with Apple
OR